| Name | ECO Animal Health Group |
|---|---|
| Epic | EAH |
| Isin | GB0032036807 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 107.67p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £72.94 | Debt ratio | n/a |
| Shares in issue | 67.74 | Debt-to-equity ratio | n/a |
| P/E ratio | 64.8 | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | 7.75 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | 1.49 | 52-week high / low | 84.00p / 131.50p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2021-09-23 | 2021-10-22 | 1.00p |
| Final | 2019-09-26 | 2019-10-16 | 7.04p |
| Interim | 2019-02-28 | 2019-04-12 | 4.00p |
| Special | 2018-12-20 | 2019-01-09 | 3.50p |
| Company name | ECO Animal Health Group |
|---|---|
| Address | The Grange, 100 High street, London, United Kingdom, N14 6BN |
| Telephone | +44 (0) 208 336 2900 |
| Website | http://www.ecoanimalhealthgroupplc.com/ |
| Director | Position |
|---|---|
| Mr David Hallas | CEO |
| Mr Christopher Wilks | CFO |
| Ms Tracey James | Non-Executive Director |
| Mr Dr. Joachim Hasenmaier | Non-Executive Director |
| Dr Frank Armstrong | Non-Executive Director |
| Dr Andrew Jones | Non-Executive Chairman |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/03/23 | 31/03/22 | 31/03/21 |
| Intangible asssets and goodwill | 35.64 | 34.3 | 36.11 |
| Investments and other non-current assets | 0.25 | 0.21 | 0.18 |
| Total non-current assets | 46.83 | 40.5 | 40.44 |
| Inventory / work in progress | 22.41 | 30.14 | 20.5 |
| Trade and other receivables | 26.85 | 25.97 | 32.45 |
| Cash and equivalents | 21.66 | 14.31 | 19.52 |
| Other current assets and asset held for resale | 3.57 | 2.67 | 3.97 |
| Total of all assets | 121.31 | 113.6 | 116.89 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 22.17 | 17.74 | 20.18 |
| Long term liabilities | 3.6 | 1.51 | 1.39 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 25.76 | 19.25 | 21.57 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 95.55 | 94.35 | 95.31 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 3.38 | 3.38 | 3.38 |
| Minority interests | 12.28 | 12.28 | 13.41 |
| Retained earnings | 13.93 | 12.41 | 13.41 |
| Share premium account | 63.32 | 63.32 | 63.26 |
| Total equity | 95.55 | 94.35 | 95.31 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 4.5 | 1.44 | 19.45 |
| Pre-tax profit | 4.44 | 1.39 | 19.31 |